SCHEMBL16809276

SCHEMBL16809276

CCNC(=O)c1ccc(CN2CCN(CC)CC2)cc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC6 Q9UBN7 3/20 0.58
HDAC1 Q13547 4/20 0.56
HDAC4 P56524 1/20 0.56
KCNH2 Q12809 1/20 0.56
HDAC8 Q9BY41 1/20 0.55
RAB9A P51151 2/20 0.55
NPC1 O15118 1/20 0.55
TP53 P04637 1/20 0.55
POLB P06746 1/20 0.55
LMNA P02545 1/20 0.54
MAPT P10636 1/20 0.54
SMN1; SMN2 Q16637 1/20 0.54
ALDH1A1 P00352 3/20 0.54
KMT2A Q03164 1/20 0.53
CHRM1 P11229 2/20 0.50
HTR2A P28223 2/20 0.50
MCHR1 Q99705 2/20 0.50
TSHR P16473 1/20 0.50
JAK2 O60674 1/20 0.50
JAK3 P52333 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8385135 0.90 HDAC6 (0.74) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL18811751 0.87 HDAC1 (0.56) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL22106236 0.87 HDAC1 (0.56) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL16810264 0.86 HDAC6 (0.60) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL19928652 0.82 POLB (0.62) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL7958723 0.82 DRD2 (0.55) HDAC6HDAC1HDAC4HDAC8KMT2A
SCHEMBL28818566 0.81 ALDH1A1 (0.61) HDAC6HDAC1HDAC4KCNH2HDAC8
SCHEMBL3013154 0.81 ALDH1A1 (0.61) HDAC6HDAC1HDAC4KCNH2RAB9A
SCHEMBL2776747 0.80 ALDH1A1 (0.59) HDAC6HDAC1HDAC4KCNH2HDAC8
Hydrochloric Acid SCHEMBL28833528 0.80 ALDH1A1 (0.59) HDAC6HDAC1HDAC4KCNH2RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2015089479-A1 METHODS TO TREAT LYMPHOPLASMACYTIC LYMPHOMA DANA-FARBER CANCER INSTITUTE, INC. (US) 2015-06-18 WO disclosed